Interestingly, the SUV intensities decreased in the rats receiving Protein vaccine-II, but not CTLA4-PD-L1-II DNA (Figures 4A, B), suggesting Protein vaccine-II may serve as a tumor vaccine to prevent TAA-induced tumorigenesis of iCCA in rats. The gene discussed is CTLA4; the disease is neoplasm.